- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.4: 12 residues within 4Å:- Chain A: G.65, F.72, L.76, M.85, W.89, S.92, L.95, G.96, A.99
- Chain B: L.240, R.241, D.341
8 PLIP interactions:3 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:L.240, A:F.72, A:F.72, A:L.76, A:L.95, A:A.99
- Hydrogen bonds: B:D.341
- Salt bridges: B:R.241
Y01.5: 11 residues within 4Å:- Chain A: L.240, R.241, M.244, D.341
- Chain B: M.68, F.72, L.76, M.85, W.89, G.96, A.99
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.240, B:M.68, B:L.76, B:W.89, B:A.99
- Hydrogen bonds: A:D.341
- Salt bridges: A:R.241
- 2 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
AV0.6: 14 residues within 4Å:- Chain A: Q.26, A.29, A.30, C.34, D.63, M.67, S.70, E.93, M.145, L.149, S.182, A.185, V.188, H.189
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:Q.26, A:A.29, A:L.149
- Hydrogen bonds: A:S.70, A:E.93, A:V.188, A:H.189
- Salt bridges: A:H.189
AV0.11: 11 residues within 4Å:- Chain B: A.30, V.33, C.34, M.67, S.70, L.149, S.182, A.185, A.186, V.188, H.189
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:A.30, B:V.33
- Hydrogen bonds: B:S.70, B:S.70, B:E.93, B:E.93
- Salt bridges: B:H.189
- 1 x 01: (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE
01.10: 7 residues within 4Å:- Chain A: I.110
- Chain B: W.105, Y.113, A.233, P.234, L.236, R.237
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.105, B:Y.113, B:Y.113, A:I.110
- Hydrogen bonds: B:R.237
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, Y. et al., Structural insights into human zinc transporter ZnT1 mediated Zn 2+ efflux. Embo Rep. (2024)
- Release Date
- 2024-10-30
- Peptides
- Probable proton-coupled zinc antiporter SLC30A3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 2 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
- 1 x 01: (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, Y. et al., Structural insights into human zinc transporter ZnT1 mediated Zn 2+ efflux. Embo Rep. (2024)
- Release Date
- 2024-10-30
- Peptides
- Probable proton-coupled zinc antiporter SLC30A3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.